BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04519437-completion@plaintrial.com
DTSTAMP:20261111T010755Z
DTSTART;VALUE=DATE:20211122
SUMMARY:Study Assessing the Safety\, Tolerability\, Pharmacokinetics\, and 
 Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2
  Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Relate
 d to COVID-19 — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04519437
URL:https://plaintrial.com/trial/NCT04519437
END:VEVENT
END:VCALENDAR